We expect all presenters to be aware of the potential of language to be stigmatising, here are two recommended guides put together by NUAA and NADA and to Girra Maa Indigenous Health start you thinking on this issue.

The Oral template is divided into two sections that you may use subject to the nature of your work. Please select the relevant section (A or B) from the two options within the template, details below.

We recommend using Section A within the template: for work which describes quantitative data or results. Authors should note that the format requires the presence of concrete results, and this will be noted when abstracts are reviewed. In the case of research in progress, where results are pending at the time of submission, we would encourage this to be noted in your submission. Subheadings for Section A are; Introduction and Aims, Design and Methods, Results, Discussion and Conclusions.

We recommend Section B: for work which is more descriptive including qualitative research, mixed methods research, policy analysis, methods papers and/or some empirical studies. Subheadings for Section B are; Introduction/Issues, Method/Approach, Key Findings, Discussions and Conclusions.

Presenters using either section of the Template are encouraged to include the two ‘optional’ points in the template; Implications for Practice or Policy and Implications for Translational Research. If you choose to do so you will be granted an additional *50 words to answer them.

Note: Your abstract will not be considered if it does not conform to the guidelines

The Scientific Advisory Committee may reallocate a presentation type on the basis of time, content, space available and applicability to the Conference themes.

Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.

APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.

For an example of a disclosure of interest/ethical statement please see below

Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study.

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

Abstracts will be favoured at review if they incorporate:

• Completed rather than future work (i.e., final results)
• Original data of high quality.
• An analysis that extends existing knowledge
• Clarity of methodology, analysis and presentation of results
• Specific rather than general findings

In balancing the program, the committee may require authors to present their work in an alternate format (e.g., as a poster rather than oral presentation).

Note: We encourage abstracts that are based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the Indigenous community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.